{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:01:43Z","timestamp":1784916103032,"version":"3.55.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Aim<\/jats:title>\n This study compared glycemic control and diabetes distress in individuals with type 1 diabetes using automated insulin delivery (AID) systems versus those not using such systems, addressing a gap in research on psychosocial outcomes of diabetes technologies.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A sequential mixed-methods design was employed to examine differences between AID users and non-users. A total of 169 individuals with type 1 diabetes completed an online survey assessing HbA1c, total diabetes distress, and its subscales. Quantitative results were complemented by 12 follow-up interviews to provide contextual depth.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The AID group (n\u2009=\u200980) showed significantly lower levels in HbA1c, total diabetes distress, and all subdimensions compared to the non-AID group (n\u2009=\u200989), which showed high CGM use (~94%). The largest effects emerged for\n Management Distress<\/jats:italic>\n and\n Powerlessness<\/jats:italic>\n . Interview data suggested that AID systems reduce the cognitive and emotional burden of diabetes self-management, which may explain these differences. Contrary to expectations, group differences in\n Hypoglycemia Distress<\/jats:italic>\n and\n Negative Social Perception<\/jats:italic>\n were smaller. This may be explained by the widespread use of continuous glucose monitoring (CGM) systems in the non-AID group, as participants from both groups reported CGM use to be helpful in reducing hypoglycemic events.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n AID systems are associated with both, improved glycemic outcomes and enhanced psychosocial well-being. These findings underscore the multifaceted benefits of AID systems and highlight the importance of incorporating psychosocial dimensions into the evaluation of diabetes technologies. The mixed-methods approach proved valuable in capturing both quantitative and experiential aspects, providing a more nuanced understanding of patient experiences.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0353125","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:26:03Z","timestamp":1784913963000},"page":"e0353125","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-7320","authenticated-orcid":true,"given":"Alexander","family":"Hadj-Abo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Gusy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8017-8088","authenticated-orcid":true,"given":"Monika","family":"Fleischhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"pone.0353125.ref001","volume-title":"IDF diabetes atlas","author":"DJ Magliano","year":"2021"},{"key":"pone.0353125.ref002","first-page":"232","article-title":"Gesundheits\u00f6konomische Aspekte des Diabetes mellitus.","volume-title":"Deutscher Gesundheitsbericht Diabetes 2024","author":"Deutsche Diabetes Gesellschaft (DDG), diabetesDE\u2013Deutsche Diabetes-Hilfe","year":"2024"},{"issue":"10138","key":"pone.0353125.ref003","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"LA DiMeglio","year":"2018","journal-title":"The Lancet"},{"key":"pone.0353125.ref004","volume-title":"Type 1 diabetes estimates in children and adults","author":"GD Ogle","year":"2022"},{"issue":"7","key":"pone.0353125.ref005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"DE Goldstein","year":"2004","journal-title":"Diabetes Care"},{"issue":"1148","key":"pone.0353125.ref006","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/postgradmedj-2020-138756","article-title":"Is HbA1c an ideal biomarker of well-controlled diabetes?","volume":"97","author":"G Kaiafa","year":"2021","journal-title":"Postgraduate Medical Journal"},{"issue":"1","key":"pone.0353125.ref007","first-page":"9","article-title":"The diabetes control and complications trial","volume":"37","author":"DM Nathan","year":"2014","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0353125.ref008","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14854","article-title":"Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"M Elbalshy","year":"2022","journal-title":"Diabet Med"},{"issue":"4","key":"pone.0353125.ref009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/dia.2007.0302","article-title":"JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods","volume":"10","author":"JDRF CGM Study Group","year":"2008","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"pone.0353125.ref010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s13300-020-00831-z","article-title":"Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas","volume":"11","author":"J Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"issue":"5","key":"pone.0353125.ref011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis","volume":"22","author":"A Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"pone.0353125.ref012","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13098-023-01144-4","article-title":"Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials","volume":"15","author":"A Godoi","year":"2023","journal-title":"Diabetology & Metabolic Syndrome"},{"key":"pone.0353125.ref013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/dia.2023.0442","article-title":"Real-World Evidence of Automated Insulin Delivery System Use","volume":"26","author":"EG Considine","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"pone.0353125.ref014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/dme.14157","article-title":"Twenty-five years of diabetes distress research","volume":"37","author":"TC Skinner","year":"2020","journal-title":"Diabet Med"},{"key":"pone.0353125.ref015","doi-asserted-by":"crossref","DOI":"10.1201\/9781003394679","volume-title":"Patient-centered medicine: transforming the clinical method","author":"M Stewart","year":"2024","edition":"4"},{"issue":"1","key":"pone.0353125.ref016","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14944","article-title":"Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review","volume":"40","author":"J Speight","year":"2023","journal-title":"Diabet Med"},{"issue":"6","key":"pone.0353125.ref017","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.18.6.754","article-title":"Assessment of diabetes-related distress","volume":"18","author":"WH Polonsky","year":"1995","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0353125.ref018","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jdiacomp.2015.01.012","article-title":"Understanding the sources of diabetes distress in adults with type 1 diabetes","volume":"29","author":"L Fisher","year":"2015","journal-title":"J Diabetes Complications"},{"issue":"11","key":"pone.0353125.ref019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11892-015-0660-z","article-title":"The detection and management of diabetes distress in people with type 1 diabetes","volume":"15","author":"J Sturt","year":"2015","journal-title":"Curr Diab Rep"},{"key":"pone.0353125.ref020","article-title":"Systematic review and meta-analysis of psychological interventions in people with diabetes and elevated diabetes-distress","author":"CB Schmidt","year":"2018","journal-title":"Diabet Med"},{"key":"pone.0353125.ref021","doi-asserted-by":"crossref","DOI":"10.1055\/s-0036-1580842","article-title":"Evaluation einer deutschen Fassung der Diabetes Distress Scale f\u00fcr Typ-1-Diabetes (T1-DDS)","volume":"11","author":"M Schipfer","year":"2016","journal-title":"Diabetologie und Stoffwechsel"},{"issue":"6","key":"pone.0353125.ref022","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1089\/dia.2021.0485","article-title":"Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System","volume":"24","author":"SC Suttiratana","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"pone.0353125.ref023","doi-asserted-by":"crossref","first-page":"109998","DOI":"10.1016\/j.diabres.2022.109998","article-title":"How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod\u00ae 5 System","volume":"190","author":"WH Polonsky","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"pone.0353125.ref024","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/dia.2021.0089","article-title":"Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial","volume":"23","author":"YC Kudva","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"pone.0353125.ref025","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/dme.12241","article-title":"Diabetes distress in Type 1 diabetes--a new measurement fit for purpose","volume":"30","author":"LE Joensen","year":"2013","journal-title":"Diabet Med"},{"key":"pone.0353125.ref026","volume-title":"Discovering statistics using IBM SPSS statistics","author":"A Field","year":"2024"},{"key":"pone.0353125.ref027","volume-title":"Essentials of statistics for the behavioral sciences","author":"FJ Gravetter","year":"2021"},{"issue":"6","key":"pone.0353125.ref028","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1089\/dia.2024.0623","article-title":"Use of Glucose Monitoring Devices Among Adults with Diabetes in Germany: Results from Nationwide Surveys Conducted in 2017 and 2021\/2022","volume":"27","author":"Y Du","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"pone.0353125.ref029","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-011-2404-1","article-title":"Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds","volume":"55","author":"S Zoungas","year":"2012","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0353125.ref030","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s12325-022-02106-4","article-title":"The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study","volume":"39","author":"KS Boye","year":"2022","journal-title":"Adv Ther"},{"issue":"4","key":"pone.0353125.ref031","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc10-1343","article-title":"Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes","volume":"34","author":"LA Gonder-Frederick","year":"2011","journal-title":"Diabetes Care"},{"key":"pone.0353125.ref032","article-title":"Vorhersage von Verbesserungen im Diabetes Distress: Eine L\u00e4ngsschnittanalyse der pr\u00e4diktiven Relevanz von psychologischer Resilienz und Akzeptanz bei Menschen mit Typ-1-Diabetes","volume":"18","author":"G Lehmann","year":"2023","journal-title":"Diabetologie und Stoffwechsel"},{"issue":"5","key":"pone.0353125.ref033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcjd.2020.08.101","article-title":"Insulin Pump Therapy Improves Quality of Life of Young Patients With Type 1 Diabetes Enrolled in a Government-Funded Insulin Pump Program: A Qualitative Study","volume":"45","author":"E Haynes","year":"2021","journal-title":"Can J Diabetes"},{"issue":"1","key":"pone.0353125.ref034","first-page":"8","article-title":"Physician\/patient relationship in diabetes mellitus type 1 treatment. A qualitative study","volume":"38","author":"MJ Escudero-Carretero","year":"2006","journal-title":"Aten Primaria"},{"issue":"2","key":"pone.0353125.ref035","first-page":"143","article-title":"Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: Systematic review","volume":"59","author":"E Tsiouli","year":"2013","journal-title":"Can Fam Physician"},{"issue":"1","key":"pone.0353125.ref036","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0265407519865613","article-title":"Implications of we-talk for relationships and health among patients with type 1 diabetes and their spouses","volume":"37","author":"J Lee","year":"2019","journal-title":"Journal of Social and Personal Relationships"},{"issue":"4","key":"pone.0353125.ref037","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/193229681200600429","article-title":"Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion","volume":"6","author":"L Heinemann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"pone.0353125.ref038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00604-023-05743-w","article-title":"Insight into continuous glucose monitoring: from medical basics to commercialized devices","volume":"190","author":"A Chmayssem","year":"2023","journal-title":"Mikrochim Acta"},{"key":"pone.0353125.ref039","volume-title":"Results of the diabetes surveillance 2015 \u2013 2024. Continuous glucose monitoring for type 1 diabetes\u2013 children and adolescents","author":"Institute NDS a t RK","year":"2024"},{"issue":"5","key":"pone.0353125.ref040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pcd.2017.03.011","article-title":"Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control","volume":"11","author":"H Trivedi","year":"2017","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"pone.0353125.ref041","doi-asserted-by":"crossref","first-page":"291","DOI":"10.15537\/smj.2022.43.3.20210536","article-title":"Self-awareness of HbA1c and its association with glycemic control among patients with type 2 diabetes: A multicenter study","volume":"43","author":"JS Almutairi","year":"2022","journal-title":"Saudi Med J"},{"issue":"1","key":"pone.0353125.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227995","article-title":"Individual differences in impulsivity and need for cognition as potential risk or resilience factors of diabetes self-management and glycemic control","volume":"15","author":"A Hadj-Abo","year":"2020","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:26:09Z","timestamp":1784913969000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353125"}},"subtitle":[],"editor":[{"given":"Hidetaka","family":"Hamasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353125","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}